Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philip N Moquist

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Journal of the American Chemical Society|November 21, 2007
Asymmetric allylboration of acyl imines catalyzed by chiral diolsSha Lou, Philip N Moquist, Scott E Schaus
Journal of the American Chemical Society|September 28, 2006
Asymmetric allylboration of ketones catalyzed by chiral diolsSha Lou, Philip N Moquist, Scott E Schaus
Organic Letters|November 10, 2011
Enantioselective boronate additions to N-acyl quinoliniums catalyzed by tartaric acidTomohiro Kodama, Philip N Moquist, Scott E Schaus
Angewandte Chemie (International Ed. in English)|July 14, 2011
Catalytic diastereoselective petasis reactionsGiovanni Muncipinto, Philip N Moquist, Stuart L Schreiber, et al.
Journal of the American Chemical Society|February 26, 2015
Enantioselective synthesis of 1,2-dihydronaphthalene-1-carbaldehydes by addition of boronates to isochromene acetals catalyzed by tartaric acidYi Luan, Keith S Barbato, Philip N Moquist, et al.
ACS Infectious Diseases|January 26, 2016
High-Throughput Screen in <i>Cryptococcus neoformans</i> Identifies a Novel Molecular Scaffold That Inhibits Cell Wall Integrity Pathway SignalingKate Hartland, Jun Pu, Michelle Palmer, et al.
The Journal of Organic Chemistry|August 18, 2025
Chiral Amino Alcohols via Catalytic Enantioselective Petasis Borono-Mannich ReactionsJohn A Kavouris, Kathryn E Kavouris, Victor Wambua, et al.
ACS Medicinal Chemistry Letters|July 16, 2025
Auristatin S: An Auristatin Payload with Improved Tolerability and Modified Bystander ActivityPhilip N Moquist, Nicole M-L Eng-Duncan, Tim D Bovee, et al.
Molecular Cancer Therapeutics|December 8, 2020
Novel Auristatins with High Bystander and Cytotoxic Activities in Drug Efflux-positive Tumor ModelsPhilip N Moquist, Tim D Bovee, Andrew B Waight, et al.
Bioconjugate Chemistry|May 24, 2024
Reversible Chemical Modification of Antibody Effector Function Mitigates Unwanted Systemic Immune ActivationPhilip N Moquist, Xinqun Zhang, Chris I Leiske, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Journal of the American Chemical Society|November 21, 2007
Asymmetric allylboration of acyl imines catalyzed by chiral diolsSha Lou, Philip N Moquist, Scott E Schaus
Journal of the American Chemical Society|September 28, 2006
Asymmetric allylboration of ketones catalyzed by chiral diolsSha Lou, Philip N Moquist, Scott E Schaus
Organic Letters|November 10, 2011
Enantioselective boronate additions to N-acyl quinoliniums catalyzed by tartaric acidTomohiro Kodama, Philip N Moquist, Scott E Schaus
Angewandte Chemie (International Ed. in English)|July 14, 2011
Catalytic diastereoselective petasis reactionsGiovanni Muncipinto, Philip N Moquist, Stuart L Schreiber, et al.
Journal of the American Chemical Society|February 26, 2015
Enantioselective synthesis of 1,2-dihydronaphthalene-1-carbaldehydes by addition of boronates to isochromene acetals catalyzed by tartaric acidYi Luan, Keith S Barbato, Philip N Moquist, et al.
ACS Infectious Diseases|January 26, 2016
High-Throughput Screen in <i>Cryptococcus neoformans</i> Identifies a Novel Molecular Scaffold That Inhibits Cell Wall Integrity Pathway SignalingKate Hartland, Jun Pu, Michelle Palmer, et al.
The Journal of Organic Chemistry|August 18, 2025
Chiral Amino Alcohols via Catalytic Enantioselective Petasis Borono-Mannich ReactionsJohn A Kavouris, Kathryn E Kavouris, Victor Wambua, et al.
ACS Medicinal Chemistry Letters|July 16, 2025
Auristatin S: An Auristatin Payload with Improved Tolerability and Modified Bystander ActivityPhilip N Moquist, Nicole M-L Eng-Duncan, Tim D Bovee, et al.
Molecular Cancer Therapeutics|December 8, 2020
Novel Auristatins with High Bystander and Cytotoxic Activities in Drug Efflux-positive Tumor ModelsPhilip N Moquist, Tim D Bovee, Andrew B Waight, et al.
Bioconjugate Chemistry|May 24, 2024
Reversible Chemical Modification of Antibody Effector Function Mitigates Unwanted Systemic Immune ActivationPhilip N Moquist, Xinqun Zhang, Chris I Leiske, et al.
Pageof 1